EMAIL DETAILS

Great, I am around later this afternoon so please let me know what
works. What they are looking for is that we tell them a roadmap for what we
would do to help them, which would include our recommendation on who we
"could/would" call on their behalf once we are shareholders. This is not
something we would need to put on writing, but rather communicate on a
call. This is our opportunity to back up the value add they perceive we
would bring. Given they just filled their coffers with $12 million
yesterday, they are looking for confirmation that our involvement will be
a meaningful net positive for them, which I have no doubt it would.

Thanks,

John

On Fri, Nov 4, 2011 at 6:28 AM, Eric Schwerin
<eschwerin@rosemontseneca.com>wrote:

> Yes, unfortunately, Hunter, Rob and I are all in the air for much of the
> day today. That said, my initial thoughts are that this would be a heavy
> lift for us. I did a quick google search on Dr. Shah there were no
> immediate avenues to him that became apparent based on his bio and prior
> experience. I also don't think any of us have any expertise in the NY
> approval process or know whether getting in front of him would even be
> helpful. I think we'd need to make a few phone calls and see what we can
> learn about this. That said, let us think more about it and John maybe I
> can call you a little later this afternoon between flights.
>
>
>
>
> Eric D. Schwerin****
> Rosemont Seneca Partners, LLC****
> 1010 Wisconsin Ave., NW****
> Suite 705****
> Washington, DC 20007****
> (202) 333-1880****
> eschwerin@rosemontseneca.com****
> *P** **Consider the environment before printing this email.*
> *
> *
>
>
>
>
> On Nov 4, 2011, at 9:04 AM, Arlene Busch wrote:
>
> John,
> Hunter, Eric, and I am all out of the office today traveling. I can't
> speak for the two of them, but I can not do a call today. I am available on
> Monday.
>
> Arlene
>
> Arlene Busch
> 202-333-1880
> Abusch@rosemontseneca.com
> ------------------------------
> *From: * John DeLoche <jdeloche@rosemontseneca.com>
> *Date: *Thu, 3 Nov 2011 20:28:12 -0700
> *To: *Hunter Biden<hbiden@rosemontseneca.com>; Devon Archer<
> darcher@rosemontcapital.com>; Eric Schwerin<eschwerin@rosemontseneca.com>;
> Rob Walker<rwalker@rosemontseneca.com>; Arlene Busch<
> abusch@rosemontseneca.com>; Neil Callahan<ncallahan@rosemontseneca.com>
> *Subject: *Input needed
>
> Hi All,
>
> Founder's Fund completed its $12mm investment in Counsyl today.
>
> I had a call with Counsyl management this evening and they asked if we
> could be helpful with regulatory channels in NY. Specifically, their lab
> and test have been approved in 49 states at this point and their lab has
> been approved by the State of New York, however the test itself is still in
> in the approval process in NY. NY and CA are two states which require
> separate lab approval and individual test approval. Counsyl has been told
> that NY's genetic test approval timing is currently as long as 12 months
> given current backlog. Specifically, they want us to help them with a
> roadmap for who we would help them contact at the NY State government level
> that could help them with this process. One idea discussed, which may or
> may not be the right one, would be to see if we can get them in front of or
> on a call with Dr. Nirav Shah, a Governor Cuomo appointee, who is
> the Commissioner for the NY State Sept of Health. The message would be that
> Counyl's test is the highest standard of care for expecting parents and it
> is currently approved in 49 states but not New York.
>
> I'd appreciate it if we could have a call to discuss. They are looking for
> high level feedback, and potentially a call with us on this subject, by
> Monday.
>
> Thanks,
>
> John
>
>
> --
> John DeLoche
> *Managing Director*
> Rosemont Seneca Technology Partners
> One Market, Spear Tower, 36th Floor
> San Francisco, CA 94105
> office: 415 293 8147
> mobile: 415 793 7070
>
> This email communication is privileged and confidential and is intended
> only for the individuals or entities named above. Any unauthorized
> dissemination of any of the contents of this email is strictly prohibited.
> If you are not the intended recipient, please do not read, copy, use or
> disclose to others the contents of this communication. Please notify the
> sender that you have received this e-mail in error and then delete the
> e-mail.
>
>
>
>


--
John DeLoche
*Managing Director*
Rosemont Seneca Technology Partners
One Market, Spear Tower, 36th Floor
San Francisco, CA 94105
office: 415 293 8147
mobile: 415 793 7070

This email communication is privileged and confidential and is intended
only for the individuals or entities named above. Any unauthorized
dissemination of any of the contents of this email is strictly prohibited.
If you are not the intended recipient, please do not read, copy, use or
disclose to others the contents of this communication. Please notify the
sender that you have received this e-mail in error and then delete the
e-mail